Why does heart surgery lead to serious damage in other organs of the body?


Heart Attack Warning Signs

Heart Attack Warning Signs

A University of Leicester-based research group funded by the British Heart Foundation and based in Leicester’s Hospitals, is to investigate why cardiac surgery can often result in serious or fatal damage to other organs in the body.

The Cardiac Surgery Research team are conducting a series of trials into why almost half of patients having heart surgery develop failure of one or more other organs, such as the lungs or kidneys.

Organ failure after cardiac surgery is now causing higher rates of mortality nationally than breast cancer.

This vital new research relies on patients volunteering to take part in clinical trials, and members of the public, many of whom are heart attack survivors themselves, have volunteered their services to help cardiac surgery research by joining the ground-breaking Patient and Public Involvement (PPI) group.

The Cardiac Surgery Research PPI group is directly helping the research team’s work as it focuses on the possible side effects of blood transfusion and whether medicines used in other treatments might help prevent organ damage, as well as whether diseases like diabetes increase the likelihood of post-surgery complications occurring.

Silvia Marian told us : “Having members of the public cast an eye over the information we give to families whose children are about to undergo heart surgery, and whose help we are asking for in our research at such a difficult time for them, has been a huge help in getting the right messages across in the right way.”

A year ago the cardiac surgery team set up their PPI group to provide valuable feedback on what the studies’ priorities should be, to make sure that the research was relevant to patients themselves, to explain it clearly, and to raise awareness of this crucial work. They have also been active in organising events at which the researchers can talk about their work and its progress.


A central part of the PPI’s role is helping the research team by ensuring that the literature given to patients and their families is clear and easy to understand and that the volunteers themselves are fully supported throughout the trials.

The PPI team have arranged for Professor Gavin Murphy, BHF Professor of Cardiac Surgery at the University of Leicester and Consultant in Cardiac Surgery at Leicester’s Hospitals, to give a lecture entitled ‘How safe is blood transfusion?’ at Loughborough University on 16 June.

Commenting on the part played by his PPI group, Professor Murphy said: “By making public and patient participation part of our research strategy we will ensure that our research best reflects the needs and concerns of the community which it aims to help.

“We would be unable to deliver our current research strategy without the commitment and time kindly given by the previous patients and members of the public who make up our PPI, which is directly making a difference to both patient experience and research success to an unprecedented extent.”

Professor Murphy is celebrating the publication in the prestigious New England Journal of Medicine (NEJM) of his latest research paper on the effects of transfusion after cardiac surgery – details of which the PPI group will be helping to circulate at local events and through social media throughout the year.

Study warns swift action needed to curb exponential climb in Ebola outbreak – says New England Journal of Medicine


Ebola Outbreak News

Ebola Outbreak News

Like many of my readers I have been following the recent Ebola outbreak with some concern. I was send the following information this morning which I thought would be useful to share.

Unless Ebola control measures in West Africa are enhanced quickly, experts from the World Health Organization (WHO) and Imperial College, London, predict numbers will continue to climb exponentially, and more than 20,000 people will have been infected by early November, according to a new article in the New England Journal of Medicine released six months after WHO was first notified of the outbreak in West Africa.

In the article, public health epidemiologists and statisticians reviewed data since the beginning of the outbreak in December 2013 to determine the scale of the epidemic, better understand the spread of the disease, and what it will take to reverse the trend of infections.

Scale of epidemic

Although WHO was first notified of the outbreak on 23 March 2014, investigations retroactively revealed the outbreak started in December 2013. Between 30 December 2013 and 14 September 2014, a total of 4507 cases were reported to WHO.


The data in the study help clarify some details of who is most affected by this outbreak. For example, there have been mixed reports on whether women might be harder hit because they are more likely to care for sick, or whether it would be men who might be more likely to bury the highly-infectious dead bodies.

“This study gave us some real insight into how this outbreak was working, for example, we learned there is no significant difference among the different countries in the total numbers of male and female case patients,” says Dr Christopher Dye, Director of Strategy for WHO, and co-author of the study. “There may be differences in some communities, but when we actually looked at all the data combined, we saw it was really almost split 50-50.”

The extensive review of data also allowed for a closer look at case fatality rate.

“Assessing the case fatality rate during this epidemic is complicated by incomplete information on the clinical outcomes of many cases, both detected and undetected,” says Dye. “This analysis shows that by 14 September, a total of 70.8% of patients with definitive outcomes have died. This rate was consistent among Guinea, Liberia and Sierra Leone.”

But the case fatality rate was lower when only hospitalized patients were considered, supporting evidence that getting patients to good, supportive health care quickly makes a difference.

Spread of infection

The examination of the data also showed the spread more clearly. In late December, the first cases were reported in the forest areas of Guinea. By March, when the government sounded the alarm to WHO, cases had already spread from the forest area to the capital of Conakry. In May, the focus of the outbreak in Guinea expanded strongly to Sierra Leone and in June it really took hold in Liberia. From July onward, there were sharp increases in case numbers in all three countries.

Projections

Although the current epidemic in West Africa is unprecedented in scale, the clinical course of infection and the transmissibility of the virus are similar to those in previous Ebola outbreaks.
“We infer that the present epidemic is exceptionally large, not primarily because of biologic characteristics of the virus, but in part because of the attributes of the affected populations, the condition of the health systems, and because control efforts have been insufficient to halt the spread of infection,” says Dye.

There are challenges in this region that exacerbate the struggles to contain the virus quickly. Most importantly the health systems in all three countries were shattered after years of conflict and there was a significant shortage of health workers, leaving the system weaker than in other countries with Ebola outbreaks. In addition, certain characteristics of the population may have led to the rapid spread of the disease, for example, the populations of Guinea, Liberia, and Sierra Leone are highly interconnected, with extensive cross-border traffic at the epicentre and relatively easy connections by road between rural towns and villages and the densely populated capital cities.
“The large intermixing population has facilitated the spread of infection, but a large outbreak was not inevitable,” says Professor Christl Donnelly, Professor of Statistical Epidemiology, Imperial College and the MRC Centre for Outbreak Analysis and Modelling. “In Nigeria, for example, where health systems are stronger, the number of cases has so far been limited, despite the introduction of infection into the large cities of Lagos and Port Harcourt.“

The critical determinant of outbreak size appears to be the speed of implementation of rigorous control measures.

“Forward projections suggest that unless control measures – including improvements in contract tracing, adequate case isolation, increased quality of care and capacity for clinical management, greater community engagement, and support from international partners – improve quickly, these three countries will soon be reporting thousands of cases and deaths each week,” says Dye.
Experimental therapeutics and vaccines offer promise for the future, but are unlikely to be available in the quantities needed to make a substantial difference in control efforts for many months, even if they are proved to be safe and effective.

The risk of continued expansion of the Ebola outbreak is real. This study provides the evidence needed for an urgent wakeup call requiring intensive scaling up of control measures while working towards rapid development and deployment of new medicines and vaccines.